Skip to main content
OpenTrials

Clinical trial condition

Urothelial Carcinoma

Explore clinical trials studying Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

243 public trials 72 recruiting studies
Refine in advanced search Browse all conditions

Urothelial Carcinoma trial results

Completed

A Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07)

NCT05524545

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Massachusett's General Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
View Trial Details
Completed

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

NCT05902494

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • University of California Irvine Orange, California, United States
  • Stanford Cancer Institute - School of Medicine Palo Alto, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 23 locations
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

NCT04242199

Conditions
Adenocarcinoma, Adenoma, Advanced Solid Tumor, +67 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Upmc Cancercenter Pittsburgh, Pennsylvania, United States
  • Md Anderson Cancer Center Houston, Texas, United States
View all 21 locations
View Trial Details
Completed

STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA

NCT03988309

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Institute of Urology, USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Avant Concierge Urology Winter Garden, Florida, United States
  • Accellacare Chicago, Illinois, United States
  • Allina Health Cancer Institute Minneapolis, Minnesota, United States
View Trial Details
Completed

Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies

NCT04383938

Conditions
Advanced Solid Tumor, Bladder Cancer, Bronchial Neoplasms, +32 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Center Boston, Massachusetts, United States
View Trial Details
Completed

Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

NCT05945108

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +16 more
Locations
  • Research Site Belo Horizonte, Brazil
  • Research Site Porto Alegre, Brazil
  • Research Site Recife, Brazil
  • Research Site Salvador, Brazil
View Trial Details
Completed

Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma

NCT03473756

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • UChicago Medicine Comprehensive Cancer Center - Hyde Park Chicago, Illinois, United States
  • Barbara Ann Karmanos Cancer Institute - Detroit Headquarters Detroit, Michigan, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View all 30 locations
View Trial Details
Completed

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

NCT03894618

Conditions
Adenocarcinoma, Anus Diseases, Anus Neoplasms, +68 more
Locations
  • The Sarah Cannon Research Institute Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Leuven Cancer Institute Leuven, Belgium
  • Princess Margaret Cancer Center Toronto, Ontario, Canada
View Trial Details
Completed

A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread

NCT05431777

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • National Hospital Organization Nagoya Medical Center Nagoya, Aichi-ken, Japan
  • Asahi General Hospital Asahi, Chiba, Japan
  • Kurume University Hospital Kurume, Fukuoka, Japan
  • Ogaki Municipal Hospital Ōgaki, Gifu, Japan
View all 16 locations
View Trial Details

Related conditions